Literature DB >> 28521877

CYP21A2 intronic variants causing 21-hydroxylase deficiency.

Paola Concolino1, Roberta Rizza2, Alessandra Costella2, Cinzia Carrozza2, Cecilia Zuppi2, Ettore Capoluongo2.   

Abstract

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder mainly caused by defects in the steroid 21-hydroxylase gene (CYP21A2). Most of CYP21A2 mutations result from intergenic recombinations between CYP21A2 and closely linked CYP21A1P pseudogene. Rare mutations not generated by gene conversion account for 5-10% of 21-hydroxylase deficiency alleles. Intronic variants represent only a little part of these but their effect on the protein is generally deleterious. The aim of this paper is to provide a comprehensive literary review regarding all intronic CYP21A2 pathological variants reported to date. In addition, we describe three novel causing disease variants in our patients affected by the classic form of CAH: IVS4-1G>A, IVS5-8T>A, IVS8-2A>G. In silico analysis revealed that all these substitutions affect the splicing process leading to a non-functional protein. Based on these results, we are able to classify them as pathological variants according to the patient's phenotype.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  21-Hydroxylase deficiency; Congenital adrenal hyperplasia; Intronic variant; Molecular diagnosis; Splicing mutations

Mesh:

Substances:

Year:  2017        PMID: 28521877     DOI: 10.1016/j.metabol.2017.03.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

Review 1.  Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.

Authors:  Paola Concolino; Alessandra Costella
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

2.  Neonatal Screening and Genotype-Phenotype Correlation of 21-Hydroxylase Deficiency in the Chinese Population.

Authors:  Xin Wang; Yanyun Wang; Dingyuan Ma; Zhilei Zhang; Yahong Li; Peiying Yang; Yun Sun; Tao Jiang
Journal:  Front Genet       Date:  2021-01-22       Impact factor: 4.599

3.  CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica.

Authors:  Andrés Umaña-Calderón; María José Acuña-Navas; Danny Alvarado; Mildred Jiménez; Fred Cavallo-Aita
Journal:  Mol Genet Metab Rep       Date:  2021-02-09

Review 4.  Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Authors:  Mirjana Kocova; Paola Concolino; Henrik Falhammar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.